Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

[1]  M. Sjoding,et al.  Racial bias and reproducibility in pulse oximetry among medical and surgical inpatients in general care in the Veterans Health Administration 2013-19: multicenter, retrospective cohort study , 2022, BMJ.

[2]  M. Shankar-Hari,et al.  Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial , 2022, Critical Care.

[3]  M. Singer,et al.  Redefining critical illness , 2022, Nature Medicine.

[4]  S. Tebbutt,et al.  A glimpse into long COVID and symptoms , 2022, The Lancet Respiratory Medicine.

[5]  M. Meade,et al.  Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial. , 2022, JAMA.

[6]  D. Brodie,et al.  Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study , 2022, BMJ.

[7]  A. Douiri,et al.  The impact of sample size mis-estimations on the interpretation of acute respiratory distress syndrome trials: systematic review and meta-analysis. , 2022, Chest.

[8]  B. Gooptu,et al.  Interstitial lung damage following COVID-19 hospitalisation: an interim analysis of the UKILD Post-COVID study. , 2022, medRxiv.

[9]  J. Laffey,et al.  Towards a biological definition of ARDS: are treatable traits the solution? , 2022, Intensive Care Medicine Experimental.

[10]  M. Shankar-Hari,et al.  Elevated ferritin is associated with systemic inflammation, inflammasome activation and mortality in Acute Respiratory Distress Syndrome (ARDS) , 2022, Acute critical care.

[11]  D. Vernerey,et al.  Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia , 2022, Annals of Intensive Care.

[12]  R. Bellomo,et al.  Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness , 2022, American journal of respiratory and critical care medicine.

[13]  D. Annane,et al.  Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial , 2022, Critical Care.

[14]  Arthur S Slutsky,et al.  Association of PEEP and Lung Recruitment Selection Strategies with Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-Analysis. , 2022, American journal of respiratory and critical care medicine.

[15]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[16]  O. Gajic,et al.  Hospital Variation in Management and Outcomes of Acute Respiratory Distress Syndrome Due to COVID-19 , 2022, Critical care explorations.

[17]  K. Borensztajn,et al.  Cathepsin S Contributes to Lung Inflammation in Acute Respiratory Distress Syndrome. , 2022, American journal of respiratory and critical care medicine.

[18]  A. Slooter,et al.  Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. , 2022, JAMA.

[19]  Clinical trial design during and beyond the pandemic: the I-SPY COVID trial. , 2022, Nature medicine.

[20]  Chun-guo Jiang,et al.  Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study , 2022, Thrombosis Journal.

[21]  Sarah L. Gillis,et al.  Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis , 2022, The Lancet Respiratory Medicine.

[22]  M. Pellegrini,et al.  Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients , 2021, Critical Care.

[23]  Arthur S Slutsky,et al.  High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19 , 2021, American journal of respiratory and critical care medicine.

[24]  D. Annane,et al.  Promises and challenges of personalized medicine to guide ARDS therapy , 2021, Critical Care.

[25]  R. Wunderink,et al.  Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial , 2021, Intensive Care Medicine.

[26]  R. Bellomo,et al.  The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study , 2021, Critical Care.

[27]  A. Zangrillo,et al.  One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation , 2021, Journal of Cardiothoracic and Vascular Anesthesia.

[28]  D. McAuley,et al.  Aspirin as a Treatment for Acute Respiratory Distress Syndrome: a randomised placebo controlled clinical trial. , 2021, Chest.

[29]  W. Ongkeko,et al.  Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status , 2021, JAMA network open.

[30]  A. Law,et al.  Death due to irreversible hypoxemic respiratory failure in ARDSnet clinical trials. , 2021, Journal of critical care.

[31]  R. Bollinger,et al.  Acute Respiratory Distress Syndrome in an African Intensive Care Unit Setting: A Prospective Study of Prevalence and Outcomes. , 2021, Annals of the American Thoracic Society.

[32]  P. Shah,et al.  CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge , 2021, Radiology.

[33]  J. McPeake,et al.  Recovery, rehabilitation and follow-up services following critical illness: an updated UK national cross-sectional survey and progress report , 2021, BMJ Open.

[34]  D. Needham,et al.  Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS , 2021, Thorax.

[35]  V. Novack,et al.  Effect of Esophageal Pressure-Guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-Based and Mechanistic Reanalysis of the EPVent-2 Trial. , 2021, American journal of respiratory and critical care medicine.

[36]  G. Perkins,et al.  Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. , 2021, JAMA.

[37]  J. Laffey,et al.  Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial , 2021, The Lancet Respiratory Medicine.

[38]  Samuel M. Brown,et al.  What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic? , 2021, Annals of the American Thoracic Society.

[39]  L. Esserman,et al.  Advancing precision medicine for acute respiratory distress syndrome , 2021, The Lancet Respiratory Medicine.

[40]  M. D. Hashem,et al.  Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial , 2021, Thorax.

[41]  I. Liem,et al.  Umbilical cord mesenchymal stromal cells as critical COVID‐19 adjuvant therapy: A randomized controlled trial , 2021, Stem cells translational medicine.

[42]  G. Perkins,et al.  RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic , 2021, Thorax.

[43]  L. Ware,et al.  Accuracy of the Radiographic Assessment of Lung Edema Score for the Diagnosis of ARDS , 2021, Frontiers in Physiology.

[44]  John N. Hutchinson,et al.  Integrative omics provide biological and clinical insights into acute respiratory distress syndrome , 2021, Intensive Care Medicine.

[45]  K. Tarte,et al.  Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection , 2021, Cell Reports Medicine.

[46]  E. Hoffman,et al.  Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length , 2021, Thorax.

[47]  Kurt L. Johnson,et al.  Association of imbalance between job workload and functional ability with return to work in ARDS survivors , 2021, Thorax.

[48]  M. Matthay,et al.  The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included? , 2021, The Lancet Respiratory Medicine.

[49]  J. McSparron,et al.  Deep learning to detect acute respiratory distress syndrome on chest radiographs: a retrospective study with external validation , 2021, The Lancet. Digital health.

[50]  D. Annane,et al.  Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis , 2021, Intensive Care Medicine.

[51]  E. Schenck,et al.  Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation , 2021, Thorax.

[52]  B. Bruce,et al.  Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region — United States, March–December 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[53]  M. Shankar-Hari,et al.  Impact of differences in acute respiratory distress syndrome randomised controlled trial inclusion and exclusion criteria: systematic review and meta-analysis , 2021, British journal of anaesthesia.

[54]  J. Beitler,et al.  The Staying Power of Pressure- and Volume-limited Ventilation in Acute Respiratory Distress Syndrome , 2021, American journal of respiratory and critical care medicine.

[55]  Arthur S Slutsky,et al.  Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome. , 2021, American journal of respiratory and critical care medicine.

[56]  A. Girbes,et al.  Between-trial heterogeneity in ARDS research , 2021, Intensive Care Medicine.

[57]  V. Kerchberger,et al.  Standardization of Methods for Sampling the Distal Airspace in Mechanically Ventilated Patients using Heat Moisture Exchange Filter Fluid. , 2021, American journal of physiology. Lung cellular and molecular physiology.

[58]  P. Horby,et al.  How the COVID-19 pandemic will change the future of critical care , 2021, Intensive Care Medicine.

[59]  J. McSparron,et al.  Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome , 2021, Annals of the American Thoracic Society.

[60]  T. Iwashyna,et al.  Benefits of Peer Support for Intensive Care Unit Survivors: Sharing Experiences, Care Debriefing, and Altruism. , 2021, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[61]  D. McAuley,et al.  ARDS Subphenotypes Beyond the Syndrome: A Step Towards Treatable Traits? , 2021, American Journal of Respiratory and Critical Care Medicine.

[62]  Janet S. Lee,et al.  COVID-19 versus Non–COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes , 2021, Annals of the American Thoracic Society.

[63]  P. Pelosi,et al.  Epidemiological Characteristics, Ventilator Management, and Clinical Outcome in Patients Receiving Invasive Ventilation in Intensive Care Units from 10 Asian Middle-Income Countries (PRoVENT-iMiC): An International, Multicenter, Prospective Study , 2021, The American journal of tropical medicine and hygiene.

[64]  A. Vuylsteke,et al.  Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service , 2021, The Lancet Respiratory Medicine.

[65]  A. Marttos,et al.  Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial , 2021, Stem cells translational medicine.

[66]  W. Lim,et al.  Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .

[67]  R. Dudley,et al.  Recent Trends in Admission Diagnosis and Related Mortality in the Medically Critically Ill , 2020, Journal of intensive care medicine.

[68]  K. Delucchi,et al.  Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS , 2020, European Respiratory Journal.

[69]  J. Laffey,et al.  Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study , 2020, European Respiratory Journal.

[70]  G. Putoto,et al.  Lung Ultrasound for Detection of Pulmonary Complications in Critically Ill Obstetric Patients in a Resource-Limited Setting , 2020, The American journal of tropical medicine and hygiene.

[71]  D. McAuley,et al.  Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential , 2020, Expert review of respiratory medicine.

[72]  S. Jaber,et al.  Prone position in ARDS patients: why, when, how and for whom , 2020, Intensive Care Medicine.

[73]  D. Elbourne,et al.  ECMO for severe ARDS: systematic review and individual patient data meta-analysis , 2020, Intensive Care Medicine.

[74]  Arthur S Slutsky,et al.  Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.

[75]  Christopher M. Horvat,et al.  Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. , 2020, JAMA.

[76]  L. Kontar,et al.  COVID-19– versus non–COVID-19–related Acute Respiratory Distress Syndrome: Differences and Similarities , 2020, American journal of respiratory and critical care medicine.

[77]  M. Shankar-Hari,et al.  Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study , 2020, The Lancet Respiratory Medicine.

[78]  M. Zeitlinger,et al.  Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey , 2020, Critical Care.

[79]  A. J. Agulló,et al.  Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS , 2020, Intensive Care Medicine.

[80]  J. McSparron,et al.  Causes and characteristics of death in patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome: a retrospective cohort study , 2020, Critical Care.

[81]  D. Consonni,et al.  Effect of mechanical power on intensive care mortality in ARDS patients , 2020, Critical Care.

[82]  M. Ramanan,et al.  A national survey of intensive care follow-up clinics in Australia. , 2020, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[83]  T. Iwashyna,et al.  Key Components of ICU Recovery Programs: What Did Patients Report Provided Benefit? , 2020, Critical care explorations.

[84]  E. Seeley,et al.  Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis , 2020, Intensive Care Medicine.

[85]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[86]  M. Fletcher,et al.  Nursing Research Priorities in Critical Care, Pulmonary, and Sleep: International Delphi Survey of Nurses, Patients, and Caregivers , 2020, Annals of the American Thoracic Society.

[87]  R. Brower,et al.  Risk factors for the development of acute respiratory distress syndrome in mechanically ventilated adults in Peru: a multicenter observational study , 2019, Critical Care.

[88]  J. Fraser,et al.  Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP): A Phase II, Multicenter, Randomized, Controlled Trial. , 2019, American journal of respiratory and critical care medicine.

[89]  Raúl San José Estépar,et al.  Semi-quantitative visual assessment of chest radiography is associated with clinical outcomes in critically ill patients , 2019, Respiratory Research.

[90]  B. Souweine,et al.  Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial. , 2019, The Lancet. Respiratory medicine.

[91]  S. Peters,et al.  Implementation of an ICU Recovery Clinic at a Tertiary Care Academic Center , 2019, Critical care explorations.

[92]  J. Chiche,et al.  Formal guidelines: management of acute respiratory distress syndrome , 2019, Annals of Intensive Care.

[93]  David T. Huang,et al.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. , 2019, The New England journal of medicine.

[94]  Nan Liu,et al.  Mechanical power normalized to predicted body weight as a predictor of mortality in patients with acute respiratory distress syndrome , 2019, Intensive Care Medicine.

[95]  Gavin D Perkins,et al.  Guidelines on the management of acute respiratory distress syndrome , 2019, BMJ Open Respiratory Research.

[96]  E. Adrario,et al.  Airway pressure release ventilation during acute hypoxemic respiratory failure: a systematic review and meta-analysis of randomized controlled trials , 2019, Annals of Intensive Care.

[97]  D. Cook,et al.  Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-FIO2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2019, JAMA.

[98]  M. Matthay,et al.  Pathogenesis of Acute Respiratory Distress Syndrome , 2019, Seminars in Respiratory and Critical Care Medicine.

[99]  M. Exline,et al.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. , 2019, The Lancet. Respiratory medicine.

[100]  N. Day,et al.  Point-of-care lung ultrasound for the detection of pulmonary manifestations of malaria and sepsis: An observational study , 2018, PloS one.

[101]  Arthur S Slutsky,et al.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial , 2018, JAMA.

[102]  Pedro Amorim,et al.  Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts , 2018, Intensive Care Medicine.

[103]  J. Laffey,et al.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[104]  M. Matthay,et al.  Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials , 2018, Respiratory Care.

[105]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome , 2018, The New England journal of medicine.

[106]  P. Pelosi,et al.  External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS , 2018, Intensive Care Medicine.

[107]  J. Bastarache,et al.  Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[108]  P. Alderson,et al.  Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors. , 2017, The Cochrane database of systematic reviews.

[109]  Victor D. Dinglas,et al.  Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1‐Year National Multicenter Study , 2017, American journal of respiratory and critical care medicine.

[110]  M. Amato,et al.  Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2017, JAMA.

[111]  P. Pronovost,et al.  Return to work and lost earnings after acute respiratory distress syndrome: a 5-year prospective, longitudinal study of long-term survivors , 2017, Thorax.

[112]  K. Langa,et al.  Late mortality after acute hypoxic respiratory failure , 2017, Thorax.

[113]  Victor D. Dinglas,et al.  Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes , 2017, Thorax.

[114]  M. Grocott,et al.  Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. , 2017, The Lancet. Respiratory medicine.

[115]  D. Needham,et al.  Healthcare utilization and costs in ARDS survivors: a 1-year longitudinal national US multicenter study , 2017, Intensive Care Medicine.

[116]  Ognjen Gajic,et al.  An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[117]  P. Pronovost,et al.  Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors* , 2017, Critical care medicine.

[118]  K. Famous,et al.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy , 2016, American journal of respiratory and critical care medicine.

[119]  A. Nica,et al.  A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study , 2017, Intensive Care Medicine.

[120]  A. Loundou,et al.  Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials , 2016, Critical Care.

[121]  L. Gattinoni,et al.  Ventilator-related causes of lung injury: the mechanical power , 2016, Intensive Care Medicine.

[122]  D. Chiumello,et al.  Airway driving pressure and lung stress in ARDS patients , 2016, Critical Care.

[123]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[124]  V. Novack,et al.  Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. , 2015, American journal of respiratory and critical care medicine.

[125]  S. McGuinness,et al.  Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers , 2015, Respiratory Care.

[126]  M. Conaway,et al.  The Adult Calfactant in Acute Respiratory Distress Syndrome Trial. , 2015, Chest.

[127]  T. West,et al.  Pulmonary ultrasound and pulse oximetry versus chest radiography and arterial blood gas analysis for the diagnosis of acute respiratory distress syndrome: a pilot study , 2015, Critical Care.

[128]  T. Walsh,et al.  Exercise rehabilitation following intensive care unit discharge for recovery from critical illness. , 2015, The Cochrane database of systematic reviews.

[129]  M. Kollef,et al.  The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. , 2015, Chest.

[130]  Arthur S Slutsky,et al.  Driving pressure and survival in the acute respiratory distress syndrome. , 2015, The New England journal of medicine.

[131]  J. Bastarache,et al.  Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury. , 2014, Clinics in chest medicine.

[132]  G. Perkins,et al.  Simvastatin in the acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[133]  Arthur S Slutsky,et al.  Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. , 2014, American journal of respiratory and critical care medicine.

[134]  Kevin Delucchi,et al.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. , 2014, The Lancet. Respiratory medicine.

[135]  Arthur S Slutsky,et al.  Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. , 2014, American journal of respiratory and critical care medicine.

[136]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[137]  A. Girbes,et al.  Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2014, PloS one.

[138]  G. Perkins,et al.  Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome. , 2013, Health technology assessment.

[139]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[140]  Marcelo Park,et al.  Clinical outcomes of patients requiring ventilatory support in Brazilian intensive care units: a multicenter, prospective, cohort study , 2013, Critical Care.

[141]  G. Tomlinson,et al.  Radiologic outcomes at 5 years after severe ARDS. , 2013, Chest.

[142]  D. Needham,et al.  One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial , 2013, BMJ.

[143]  Duncan Young,et al.  High-Frequency Oscillation for Acute Respiratory Distress Syndrome , 2013 .

[144]  Arthur S Slutsky,et al.  High-frequency oscillation in early acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[145]  Ó. Peñuelas,et al.  Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. , 2013, American journal of respiratory and critical care medicine.

[146]  J. Reitsma,et al.  Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic Tests , 2012 .

[147]  Richard Beale,et al.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[148]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[149]  Lung,et al.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[150]  M. Plataki,et al.  Lung ultrasound in critically ill patients: comparison with bedside chest radiography , 2011, Intensive Care Medicine.

[151]  Arthur S Slutsky,et al.  Functional disability 5 years after acute respiratory distress syndrome. , 2011, The New England journal of medicine.

[152]  K. Iwata,et al.  Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. , 2010, Internal medicine.

[153]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.

[154]  M. Siegel,et al.  Randomized clinical trial of activated protein C for the treatment of acute lung injury. , 2008, American journal of respiratory and critical care medicine.

[155]  D. Needham,et al.  Psychiatric Morbidity in Survivors of the Acute Respiratory Distress Syndrome: A Systematic Review , 2008, Psychosomatic medicine.

[156]  R. Hyzy,et al.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. , 2006, The New England journal of medicine.

[157]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[158]  C. Moorehead.  All rights reserved , 1997 .

[159]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[160]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.